Hydroflumethiazide

氢氟噻嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameHydroflumethiazide
Drug Alias Name氢氟甲噻嗪Hydroflumethiazidum双氢氟噻嗪氢氟甲噻Diucardin +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporter
Therapy Area/IndicationsHypertensionHeart Failure
Global Approved IndicationsHypertensionHeart Failure
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1959/07/22
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesShire Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShire Llc
Active IndicationsN/A
Inactive IndicationsHypertensionHeart Failure

Other Information

ATC CodeC03AA02
Related LinksWikipediaDrugBankKEGG